NCT07535177

Brief Summary

This study aimed to investigate gingival crevicular fluid (GCF) and serum soluble MerTK (sMerTK) and Gas6 levels in periodontal health and disease. A total of 90 individuals, 30 patients with stage III grade B periodontitis, 30 with gingivitis and 30 periodontally healthy individuals were included. Whole-mouth and site-specific clinical periodontal parameters including probing depth, clinical attachment level, bleeding on probing, gingival index, plaque index were recorded. GCF and serum sMerTK and Gas6 levels were measured by enzyme-linked immunosorbent assay. Statistical analysis was performed by using non-parametric tests.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress42%
Mar 2026May 2026

Study Start

First participant enrolled

March 25, 2026

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

April 2, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 16, 2026

Completed
24 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2026

Expected
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2026

Last Updated

April 16, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 2, 2026

Last Update Submit

April 9, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Gas6 Levels in Gingival Crevicular Fluid

    Quantitative measurement of Gas6 levels (pg/mL) in gingival crevicular fluid samples using enzyme-linked immunosorbent assay (ELISA), and comparison of these levels among periodontally healthy, gingivitis, and periodontitis groups.

    baseline

  • Soluble MerTK (sMerTK) Levels in Gingival Crevicular Fluid

    Quantitative measurement of soluble MerTK (sMerTK) levels (pg/mL) in gingival crevicular fluid samples using enzyme-linked immunosorbent assay (ELISA), and comparison of these levels among periodontally healthy, gingivitis, and periodontitis groups.

    baseline

Secondary Outcomes (4)

  • Plaque Index

    baseline

  • Probing Depth

    baseline

  • Clinical Attachment Loss

    baseline

  • Gingival Index

    baseline

Study Arms (3)

periodontally healthy (H) group

Other: gingival crevicular fluid collection

gingivitis (G) group

Other: gingival crevicular fluid collection

stage III grade B periodontitis (P) group

Other: gingival crevicular fluid collection

Interventions

Gingival crevicular fluid collection using sterile paper strips inserted into the gingival sulcus for 30 seconds from selected periodontal sites (healthy, gingivitis, and periodontitis) for biomarker analysis (Gas6 and sMerTK).

gingivitis (G) groupperiodontally healthy (H) groupstage III grade B periodontitis (P) group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This clinical study will be conducted on individuals who apply to the Department of Periodontology, Faculty of Dentistry, Abant İzzet Baysal University.

You may qualify if:

  • Individuals without systemic diseases that may affect periodontal tissues (such as cardiovascular diseases, atherosclerosis, immune system disorders, rheumatoid arthritis, obesity, cancer, and diabetes)
  • Individuals who have not used antibiotics within the last 3 months
  • Individuals not taking any medications known to affect periodontal tissues
  • Individuals without infectious diseases such as HIV, hepatitis B virus (HBV), or tuberculosis
  • Individuals with at least 16 natural teeth, excluding third molars
  • Individuals aged 18 years and older

You may not qualify if:

  • Pregnant or lactating individuals
  • Individuals who have received periodontal treatment within the last 6 months
  • Current smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bolu Abant Izzet Baysal University Faculty of Dentistry

Bolu, Bolu, 14030, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 2, 2026

First Posted

April 16, 2026

Study Start

March 25, 2026

Primary Completion (Estimated)

May 10, 2026

Study Completion (Estimated)

May 20, 2026

Last Updated

April 16, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations